CCL4 mitigates dendritic cell migration and subsequent T cell activation and tumor infiltration7, while CCL5, CXCL9, and CXCL10 are associated with T cell infiltration across solid tumors8–15. The gene discussed is CCL5; the disease is neoplasm.